Articles, App Notes, Case Studies, & White Papers

  1. mRNA: How To Build A Custom Program Using CDMO Services 1/4/2023

    Development of RNA-based therapies sits at the cutting edge of vaccine and oncology innovation, in addition to holding promise in dozens of other therapeutic areas.

  2. Obtaining Good Yields With High Purity Of An N-terminal Histidine-Tagged Protein 10/16/2013

    ÄKTA start eliminates the hassles of manual protein purification handling, such as loading large sample volumes and continually monitoring UV readings, and can give you consistency of yield and purity. Madhu demonstrates how ÄKTA start aided him in purifying a recombinant N-terminal histidine-tagged protein.

  3. The Source Of GMP- How Client Demand Drives Innovation 1/13/2021

    GMP-Source, which is a term we coined, serves the purpose as a highly qualified raw material for a generation of virus, messenger RNA template, and transgenic expression of proteins. 

  4. Solid Tumors: Asia Pacific Clinical Trial Landscape 9/29/2022

    Read more about how the large population and lower volume of studies decreases competing trial risk in this region with a great need for novel drug therapies for solid tumors in Asian patients

  5. Overview Of Parkinson's Disease: Global Clinical Trials Landscape 12/27/2024

    Parkinson's disease affects over 8.5 million globally. Explore how advances in gene therapy, Deep Brain Stimulation, and innovative drugs are transforming treatment and improving patient outcomes.

  6. Future-Proofing mRNA Drug Manufacturing: The Value of Continuous Improvement 4/30/2024

    With so many uncertainties permeating the mRNA market, this largely preclinical industry is still seeking answers on how to reach successful therapeutic development. Identifying optimizations, both sequence-dependent and otherwise, to enhance the manufacturing process is crucial for advancing mRNA product development, which holds vast potential to address a wide range of indications.

  7. Overview Of Diffuse Large B-cell Lymphoma: Global Clinical Trial Landscape 11/15/2024

    Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma subtype, has varied molecular profiles, global incidence, innovative drugs, and trials improving treatment strategies and patient outcomes.

  8. Uncovering Hidden CRO Contract Costs Before Signing A Contract 1/22/2024

    Navigating the complex landscape of clinical trials can be challenging. Utilize this reliable CRO Checklist to empower teams to stay ahead and safeguard every trial's budget effectively.

  9. Ultra-Sensitive Assay For Anti-Sense Oligonucleotide Quantification 3/1/2022

    Learn about a new level in sensitivity for challenging analytes in matrix that opens doors for accurate bioanalysis and metabolism studies with specificity not achievable with orthogonal methods.

  10. The Biotech Landscape: Opportunities In China And The Path To USFDA Approval 11/7/2022

    In this white paper, learn why western biopharma companies should take advantage of China’s revamped regulatory framework.